FBT
First Trust NYSE Arca Biotechnology Index Fund·ARCA
--
--(--)
--
--(--)
Key Stats
Assets Under Management
2.18BUSD
Fund Flow (1Y)
1.08BUSD
Dividend Yield
0.61%
Discount / Premium to NAV
-0.07%
Shares Outstanding
11.40M
Expense Ratio
0.54%
About First Trust NYSE Arca Biotechnology Index Fund
Issuer
First Trust Advisors L.P.
Brand
First Trust
Inception Date
Jun 19, 2006
Structure
Open-Ended Fund
Index Tracked
NYSE Arca Biotechnology Index
Management Style
Passive
Dividend Treatment
Distributes
Distribution Tax Treatment
Qualified dividends
Income Tax Type
Capital Gains
Max ST Capital Gains Rate
39.60%
Max LT Capital Gains Rate
20.00%
Primary Advisor
First Trust Advisors LP
Distributor
First Trust Portfolios LP
FBT provides exposure to biotech companies involved in the use of biological processes to develop products or provide services. The underlying index contains 30 names, an increase from 20 in October 2014. Without a specific sector classification scheme, the fund's broad exposure could include access to pharmaceuticals and medical technology in addition to traditional biotech. Still, FBT's equal weighting of about 30 stocks produces a relatively concentrated basket. The index is reconstituted and rebalanced quarterly.
Classification
Asset Class
Equity
Category
Sector
Focus
Health Care
Niche
Biotechnology
Strategy
Equal
Geography
U.S.
Weighting Scheme
Equal
Selection Criteria
Market cap
Analysis
Holdings
Symbol
Ratio
MRNA
Moderna
5.56%
GILD
Gilead Sciences
4.22%
UTHR
United Therapeutics
4.01%
AMGN
Amgen
3.99%
EXAS
Exact Sciences
3.82%
Symbol
Ratio
BIIB
Biogen
3.64%
VRTX
Vertex Pharmaceuticals
3.62%
KRYS
Krystal Biotech
3.56%
EXEL
Exelixis
3.50%
NBIX
Neurocrine Biosciences
3.48%
Top 10 Weight 39.4%
31 Total Holding
See all holdings
Related Funds
Seasonals
Volume Profile
Trade Flow Insight
Community
Loading...
Related News
No articles available
You can ask Aime
No Data
